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1.1. Methods for modifying cyclic peptides
Cyclic peptides have risen in popularity in recent years as
new methods for parallel synthesis of these macrocycles have
emerged. Their larger size, conformational ﬂexibility, metabolic
stability and potential for drug-like properties makes them
attractive options for drug discovery against more challenging
protein-protein interaction targets. There have been many new
methods reported that allow access to large libraries of cyclic
peptides, but a recent paper describes an innovative synthetic
method for introducing new amino acid fragments into these
macrocycles [1].
The advantages of N-acyl aziridines have been explored as pre-
cursors to both natural and unnatural amino acids. For example
nucleophilic opening of aziridines with thiols leads to modiﬁed
amino acid sidechains. It has also been noted that acyl aziridines
rapidly undergo hydrolysis as a consequence of signiﬁcant amide
bond distortion resulting from the nitrogen pyrimidalisation.
Although it can be a liability, this reactivity has been turned into
an asset in this new study facilitating site-speciﬁc amino acid
introduction.
The approach has been exempliﬁed with a cyclic tetrapeptide
(1) in which one of the amino acids is represented by an aziridine
carboxylic acid. When treated with aqueous lithium hydroxide,
the aziridine amide bond can be selectively cleaved to quantita-
tively generate a linear tetrapeptide (2).This material was fully
stable to storage as long as it was kept as a C-terminal carboxyl-
ate salt. At this point, it was possible to introduce the new amino
acid fragment (for example glycine ethyl ester) using the coupling
reagent, (7-azabenzotriazol-1-yloxy)tris(dimethylamino)phospho-
nium hexaﬂuorophosphate (AOP). It was feared that the unpro-
tected aziridine nitrogen might also participate in a coupling
reaction but it was found that only minor amounts of oligomer-
ised product were generated, the major product being the
expected linear pentapeptide (3). Ester hydrolysis proceeded with
lithium hydroxide, and cyclisation to the cyclic pentapeptide (4)
was achieved under AOP coupling conditions without any evi-
dence of oligomerisation. Similar reactions could be employed
to successfully insert larger fragments such as dipeptides and
tripeptides.http://dx.doi.org/10.1016/j.comche.2014.04.001
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At this point the authors investigated methods for further
diversiﬁcation by using nucleophilic opening of the aziridine ring.
Treatment of the cyclic pentapeptide with sodium azide resulted
18 N.K. Terrett / Combinatorial Chemistry - An Online Journal 16 (2014) 17–20in regioselective attack onto the b-carbon of the aziridine with ring
opening to give product 5 that could be further derivatised. In addi-
tion to this product, there were varying degrees of elimination of
the azide to give the a,b-unsaturated product 6.
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Overall, this method employs the reactivity of N-acylaziridine to
amide hydrolysis to selectively cleave cyclic peptides, and introduce
new amino acid fragments. In this way it is possible to rapidly
diversify cyclic peptide libraries, and the reversibility of N-acyl azi-
ridine formation provides potential applications in dynamic combi-
natorial chemistry.2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
A novel strategy of solid phase synthesis of N-cycloguanidinyl-
formyl peptides has been established. The method involves cou-
pling orthogonally protected diaminoacids with a resin bound pep-
tide, followed by a-amino group deprotection, guanidinylation of
the a-amino group by bis-Cbz-1H-pyrazole-1-carboxamidine fol-
lowed by cleavage and cyclisation in solution, and ﬁnally removing
Cbz by palladium catalysed hydrogenation. Through this method,
cycloguanidine could be introduced to either N-terminus or side-
chain of designated peptides. The reaction conditions were facile,
straightforward, and adaptable to common solid phase peptide
synthesis strategy [2].
2.2. Solution-phase synthesis
A small library of hitherto unprepared pyrazolo[3,4-d]-4,5-
dihydropyrimidin-6-ones was synthesised on a preparative scale.The synthesis started with a substituted 5-aminopyrazole that
reacted with an isocyanate to give the corresponding urea. This
undergoes a chlorotrimethylsilane-promoted [5+1] cyclocondensa-
tion with an aldehyde yielding the title pyrazolo[3,4-d]-4,
5-dihydropyrimidin-6-one. Both synthetic steps are high-yielding
(74–94%). The intermediates and the target compounds were
isolated by simple crystallisation [3].
2.3. Scaffolds and synthons for combinatorial libraries
1,3- and 1,4-disubstituted piperidines are important building
blocks in medicinal chemistry and drug discovery. The synthesis
of orthogonally protected piperidin-3-ylmethanamine and piperi-
din-4-ylmethanamine derivatives from commercially available
nipecotamide, isonipecotamide, nipecotic acid and isonipecotic
acid has been described. This is a straightforward two-step proce-
dure that gives high overall yields. Puriﬁcation of the intermediates
using this procedure is not necessary, and the ﬁnal compounds are
puriﬁed by simple ﬂash column chromatography [4].
2.4. Solid-phase supported reagents
A highly efﬁcient protocol for the library synthesis of biologi-
cally important 3H,30H-spiro[benzofuran-2,10isobenzofuran]-3,30-
diones has been developed by employing silica sulphuric acid
(SSA) as solid acid support under solvent-free condition. The dual
characteristics of SSA, as an activating agent as well as oxidising
agent, have been well exposed in these syntheses. The intrinsic
advantages of the methodology are the use of solvent-free reaction
condition without using any toxic reagents or metal catalyst, oper-
ational simplicity, recyclability of the solid support, good availabil-
ity of the starting materials, and excellent yields [5].
A cost-effective and eco-friendly synthesis of 2-aryl-1-aryl-
methyl-1H-benzimidazoles has been developed through the con-
densation of different aldehydes with o-phenylenediamine using
alumina-sulphuric acid as a recyclable heterogeneous solid acid
catalyst. Morphological properties of the catalyst have been inves-
tigated and the effect of different solvents and comparison of alu-
mina-sulphuric acid with different acid catalysts have also been
studied. A plausible mechanistic pathway has been proposed on
the basis of the isotope labelling experiments where catalytic
behaviour of alumina-sulphuric acid has been explained [6].
2.5. Novel resins, linkers and techniques
Solid-phase oligopeptide synthesis has been well developed and
most short oligopeptides can now be easily synthesised. However,
when a desired oligopeptide forms a secondary structure or
includes less reactive amino acids such as aminoisobutyric acid,
its terminal amino groups become less reactive and synthesis of
the desired oligopeptides becomes difﬁcult. To expand the number
of accessible synthetic peptide sequences, an efﬁcient coupling
condition using 3-nitro-1,2,4-triazol-l-yl-tris(pyrrolidin-1-yl)phos-
phonium hexaﬂuorophosphate (PyNTP) as a highly reactive con-
densing reagent on an unswellable solid support has been
developed. PyNTP demonstrated higher reactivity than conven-
tional condensing reagents and the optical purity of the synthes-
ised oligopeptides was sufﬁciently high for application to general
oligopeptide synthesis [7].
A combinatorial library of pyranopyrazoles and chromenopy-
razoles has been regioselectively synthesised in excellent yield
from ethylacetoacetate, hydrazinehydrate, substituted aldehyde/
salicylaldehyde with nitroketene-N,S-acetal in the presence of
piperidine under solvent-free conditions. This novel strategy
avoids tedious extraction, chromatographic separation and recrys-
tallisation processes, as the ﬁnal product could be obtained by
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mixture [8].
2.6. Library applications
The potency of a series of hexamethylene bis-acetamide
(HMBA) derivatives inducing hexamethylene bis-acetamide induc-
ible protein 1 has been determined in LNCaP prostate cancer cells.
Several compounds with unsymmetrical structures showed signif-
icantly improved activity. Distinct from HMBA, these analogues
have increased hydrophobicity and can improve the short half-life
of HMBA; one of the factors that have limited the application of
HMBA in clinics. The unsymmetrical scaffolds of the new analogs
provide the basis for further lead optimisation of the compounds
using combinatorial chemistry strategy [9].
The design, synthesis and biological evaluation of novel triazol-
yl p38a MAPK inhibitors with improved water solubility for for-
mulation in cationic liposomes targeted at diseased endothelial
cells have been described. Water-solubilising groups were
introduced via a ‘click’ reaction of functional azides with 2-alkynyl
imidazoles and isosteric oxazoles to generate two small libraries of
1,4-disubstituted 1,2,3-triazolyl p38a MAPK inhibitors. Triazoles
with low IC50 values and desired physicochemical properties
were screened for in vitro downregulation of proinﬂammatory
gene expression and were formulated in these cationic liposomes
[10].
A small library of monovalent Smac mimics with general struc-
ture NMeAla-Tle-(4R)-4-Benzyl-Pro-Xaa-cysteamide, has been
synthesised (Xaa = hydrophobic residue). The library was screened
in vitro against human breast cancer cell lines MCF-7 and MDA-
MB-231, and the two most active compounds oligomerised via S-
alkylation giving bivalent and trivalent derivatives. The most active
bivalent analogue SMAC17-2X was tested in vivo in a mouse model
where it exerted a potent anticancer effect resulting in 23.4 days
of tumor growth delay at a dose of 7.5 mg/kg [11].
Apoptosis is regulated by the BCL-2 family of proteins, which is
comprised of both pro-death and pro-survival members. Evasion of
apoptosis is a hallmark of malignant cells, and one way in which
cancer cells achieve this evasion is through overexpression of the
pro-survival members of the BCL-2 family. Overexpression of
MCL-1, a pro-survival protein, has been shown to be a resistance
factor and the use of fragment screening methods and structural
biology to drive the discovery of novel MCL-1 inhibitors has been
described. Cores derived from a biphenyl sulphonamide and sali-
cylic acid were revealed in an NMR-based fragment screen and
elaborated using high throughput analogue synthesis. This culmi-
nated in the discovery of selective and potent inhibitors of MCL-
1 that may serve as promising leads for medicinal chemistry opti-
misation efforts [12].
The discovery of novel reverse tricyclic pyridones as inhibitors
of Janus kinase 2 (JAK2) has been reported. By using a kinase cross
screening approach coupled with molecular modeling, a unique
inhibitor–water interaction was discovered that imparted excel-
lent broad kinase selectivity. Improvements in intrinsic potency
were achieved by using a rapid library approach, while targeted
structural changes to lower lipophilicity led to improved rat phar-
macokinetics [13].
A series of novel 3-indolyl cyclopent[b]indoles have been gener-
ated by triﬂuoroacetic acid-mediated cyclodimerisations. The reac-
tion showed high stereoselectivity and moderate to good yields.
The cell viability tests in two colon and two lung cancer cell lines
indicated the 1-benzyl-2-phenyl-group in 3-indolyl cyclo-
pent[b]indoles was critical for the observed lower IC50s in these
compounds. Western blot analysis demonstrated that the com-
pound inhibited the expression and phosphorylation of EGFR
through altered HSP90 expression [14].References
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